Your browser doesn't support javascript.
loading
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine.
Correale, Pierpaolo; Botta, Cirino; Staropoli, Nicoletta; Nardone, Valerio; Pastina, Pierpaolo; Ulivieri, Cristina; Gandolfo, Claudia; Baldari, Tatiana Cosima; Lazzi, Stefano; Ciliberto, Domenico; Giannicola, Rocco; Fioravanti, Antonella; Giordano, Antonio; Zappavigna, Silvia; Caraglia, Michele; Tassone, Pierfrancesco; Pirtoli, Luigi; Cusi, Maria Grazia; Tagliaferri, Pierosandro.
Afiliação
  • Correale P; Unit of Medical Oncology, Grand Metropolitan Hospital Bianchi Melacrino Morelli, Reggio-Calabria, Italy.
  • Botta C; Medical Oncology Unit, AUO Mater Domini, Magna Graecia University, Catanzaro, Italy.
  • Staropoli N; Department of Experimental and Clinical Medicine, Magna Graecia University , Catanzaro, Italy.
  • Nardone V; Unit of Radiotherapy, Department of Surgery, Medicine and Neurological Science, Siena University Hospital, Siena, Italy.
  • Pastina P; Unit of Radiotherapy, Department of Surgery, Medicine and Neurological Science, Siena University Hospital, Siena, Italy.
  • Ulivieri C; Department of Science of Life, Siena University, Siena, Italy.
  • Gandolfo C; Microbiology and Virology Unit, Department of Medical Biotechnology, Siena University, Siena, Italy.
  • Baldari TC; Department of Science of Life, Siena University, Siena, Italy.
  • Lazzi S; Unit of Pathology, Department of Surgery, Medicine and Neurological Science, Siena University Hospital, Siena, Italy.
  • Ciliberto D; Department of Experimental and Clinical Medicine, Magna Graecia University , Catanzaro, Italy.
  • Giannicola R; Unit of Medical Oncology, Grand Metropolitan Hospital Bianchi Melacrino Morelli, Reggio-Calabria, Italy.
  • Fioravanti A; Unit of Rheumatology, Department of Clinical Medicine and Immunologic Sciences, University of Siena, Siena, Italy.
  • Giordano A; Department of Biotechnology, Temple University, Sbarro Foundation, Philadelphia, Pennsylvania, USA.
  • Zappavigna S; Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy.
  • Caraglia M; Department of Biotechnology, Temple University, Sbarro Foundation, Philadelphia, Pennsylvania, USA.
  • Tassone P; Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy.
  • Pirtoli L; Medical Oncology Unit, AUO Mater Domini, Magna Graecia University, Catanzaro, Italy.
  • Cusi MG; Department of Experimental and Clinical Medicine, Magna Graecia University , Catanzaro, Italy.
  • Tagliaferri P; Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy.
Oncotarget ; 9(29): 20539-20554, 2018 Apr 17.
Article em En | MEDLINE | ID: mdl-29755670
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article